Â鶹Èë¿Ú

Â鶹Èë¿Ú is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…

Â鶹Èë¿Ú represents Aetna Inc. and its subsidiaries ActiveHealth Management, Inc. and Medicity, Inc. in a patent infringement suit brought by HealthTrio, LLC. HealthTrio filed the lawsuit…

Â鶹Èë¿Ú represents Transcend Medical, Inc., an innovator in the field of Micro-Invasive Glaucoma Surgery, in a patent suit against Glaukos Corporation. Transcend has recently completed a…

Â鶹Èë¿Ú is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by OPKO Health, Inc. Under the terms of the agreement, holders of Bio…

Â鶹Èë¿Ú is advising Warner Chilcott plc in connection with its approximately $8.5 billion acquisition by Actavis, Inc. in a stock-for-stock transaction. The transaction is expected to…

On August 5, 2011, the Office of Inspector General for the Department of Health and Human Services dropped a potential action against Â鶹Èë¿Ú client Howard Solomon, the President,…

Â鶹Èë¿Ú represented VNUS Medical in patent infringement litigation since 2005 in the Northern District of California. VNUS, the pioneer in endovenous treatment for varicose veins, sued…

On January 20, 2009, the Delaware Court of Chancery heard oral argument and denied a Ventana Medical Systems, Inc. shareholder’s mootness petition for attorneys’ fees against Â鶹Èë¿Ú…